Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trial of Celecoxib /OR Nsaid/ for Prevention of Spor-261995015
Strang Cancer Prevention Cent
Search grants from Strang Cancer Prevention Cent
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
ERK/MAPK regulation of cortical inhibitory interneurons
MAT1 Null Mouse: Model for Alcoholic Tissue Injury
Okolakiciye Unyukinipi
Molecular Characterization of Acf (Aberrant Crypt Foci)
Recently added grants:
Intraventricular hemorrhage affects production of cortical interneurons
State-dependent interaction of antiepileptic drugs with voltage-dependent sodium channels and differential regulation of excitatory and inhibitory central neurons
Mutant Mouse Resource and Research Center at UC Davis
The Resource of the MMRRC at UC Davis
Research Projects #1 and #2
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN995015-001
Application #
6994841
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2004
Total Cost
Indirect Cost
Institution
Name
Strang Cancer Prevention Cent
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase II Clinical Trial of Celecoxib /OR Nsaid/ for Prevention of Spor-261995015
/ Strang Cancer Prevention Cent
NIH 2004
N01 CN
Phase II Clinical Trial of Celecoxib /OR Nsaid/ for Prevention of Spor-261995015
/ Strang Cancer Prevention Cent
Comments
Be the first to comment on this grant